Asosiy kontentga oʻtish
Maqola

Phospholipase C Enzymes as Bidirectional Regulators of Macrophage Immunocompetence and Intraphagosomal Fate During Mycobacterium Tuberculosis Infection (Review)

Irodaxon Yusupovna MamatovaAndijan State Medical Institute, AndijanR. A. KhakimovaAndijan State Medical Institute, AndijanA.A. KhushnudbekovAndijan State Medical Institute, AndijanS.G. ArtikovaAndijan State Medical Institute, AndijanA.A. MakhkamovAndijan State Medical Institute, Andijan
2026en
ABI

Annotatsiya

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), reclaimed its position as the leading cause of death from a single infectious agent, with 1.25 million deaths reported in 2023. The ability of Mtb to establish a replicative niche inside alveolar macrophages — the very cells responsible for its destruction — depends on the subversion of host intracellular signalling. Phospholipase C (PLC) enzymes, which hydrolyse phosphatidylinositol 4,5-bisphosphate into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), occupy a uniquely contested position in this host—pathogen dialogue: they are simultaneously indispensable effectors of macrophage antimicrobial activation and exploitable substrates of Mtb immune evasion. Objective — to construct a comprehensive mechanistic framework delineating how host PLC isoforms and bacterially encoded Mtb phospholipases C (plcA—plcD) exert opposing regulatory influences on macrophage activation state, phagosomal maturation dynamics, and cell death modality, and to evaluate contemporary evidence supporting PLC pathways as targets for host-directed therapy. Materials and methods. A systematic review of peer-reviewed literature was conducted across PubMed/MEDLINE, Scopus, and Web of Science for the period January 2020 — December 2025, in accordance with the PRISMA 2020 statement. Eligible studies addressed PLC biology in macrophage activation, Mtb virulence, phagosome biology, host cell death, or host-directed therapy; review articles were used for contextualisation. Results and discussion. Host PLC isoforms drive pro-inflammatory macrophage activation through the DAG/protein kinase C/NF-κB and IP3/Ca2+/calmodulin cascades, supporting reactive oxygen and nitrogen species output and phagolysosome biogenesis. PLCε1 emerges as a non-redundant host-protective factor: it is the most strongly suppressed gene in TB progressors in cross-species transcriptomic analyses, and its genetic ablation increases lung bacterial burden and M2 polarisation in mice. Conversely, Mtb-encoded PLCs are upregulated within hours of phagocytosis, hydrolyse host membrane phospholipids, suppress the COX-2/PGE2 axis, and favour necrotic over apoptotic macrophage death — a modality that promotes bacterial dissemination. In parallel, mannose-capped lipoarabinomannan intercepts the PLC-derived IP3—Ca2+ transient required for calmodulin-dependent PI3K-hVPS34 activation, arresting phagosome maturation at a pre-lysosomal stage. The balance between PGE2-driven apoptosis and necrosis/pyroptosis is now recognised as a determinant of disease trajectory. Conclusions. The PLC signalling axis constitutes a molecular fault line at the macrophage—Mtb interface, simultaneously supporting host defence and being co-opted for immune subversion. Pharmacological augmenta­tion of the host PLCε1 pathway, selective inhibition of mycobacterial PLCs, restoration of the PGE2/COX-2 axis, and rescue of phagosomal Ca2+ signalling represent mechanistically grounded avenues for host-directed TB therapy that warrant further preclinical and clinical investigation.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar